311.43
                                            
            Bio Rad Laboratories Inc stock is traded at $311.43, with a volume of 252.59K.
            It is down -2.54% in the last 24 hours and up +1.94% over the past month.
            Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
        
        See More
    Previous Close:
              $319.55
            Open:
              $317.04
            24h Volume:
                252.59K
            Relative Volume:
              1.00
            Market Cap:
                $6.85B
            Revenue:
              $2.58B
            Net Income/Loss:
              $-778.69M
            P/E Ratio:
              -11.40
            EPS:
                -27.33
            Net Cash Flow:
                $223.75M
            1W Performance:
              -7.35%
            1M Performance:
              +1.94%
            6M Performance:
                +31.77%
            1Y Performance:
              -15.47%
            Bio Rad Laboratories Inc Stock (BIO) Company Profile
Name
                  
                      Bio Rad Laboratories Inc
                    
                Sector
                  Industry
                  Phone
                  
                      (510) 724-7000
                    
                Address
                  
                      1000 ALFRED NOBEL DRIVE, HERCULES
                    
                Compare BIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                BIO
                            
                             
                        Bio Rad Laboratories Inc 
                           | 
                    311.43 | 8.62B | 2.58B | -778.69M | 223.75M | -27.33 | 
| 
                         
                          
                                ABT
                            
                             
                        Abbott Laboratories 
                           | 
                    123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 | 
| 
                         
                          
                                BSX
                            
                             
                        Boston Scientific Corp 
                           | 
                    98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 | 
| 
                         
                          
                                SYK
                            
                             
                        Stryker Corp 
                           | 
                    358.16 | 136.23B | 24.38B | 2.94B | 4.07B | 7.6159 | 
| 
                         
                          
                                MDT
                            
                             
                        Medtronic Plc 
                           | 
                    90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 | 
| 
                         
                          
                                EW
                            
                             
                        Edwards Lifesciences Corp 
                           | 
                    83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 | 
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change | 
|---|---|---|---|
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy | 
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight | 
| Jun-03-24 | Resumed | Jefferies | Hold | 
| Apr-03-24 | Downgrade | Citigroup | Buy → Neutral | 
| Dec-07-23 | Initiated | UBS | Buy | 
| Jun-16-23 | Initiated | Wells Fargo | Overweight | 
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform | 
| Aug-25-22 | Initiated | Credit Suisse | Outperform | 
| Jan-28-22 | Reiterated | Citigroup | Buy | 
| Jan-08-20 | Initiated | Wells Fargo | Overweight | 
| Jan-07-20 | Initiated | Citigroup | Buy | 
| Oct-17-18 | Initiated | Goldman | Buy | 
| Sep-20-18 | Initiated | Morgan Stanley | Equal-Weight | 
| Feb-16-18 | Downgrade | CL King | Buy → Neutral | 
| Jul-13-17 | Initiated | Wells Fargo | Outperform | 
| Jun-28-17 | Upgrade | Deutsche Bank | Hold → Buy | 
| Jan-18-17 | Initiated | Deutsche Bank | Hold | 
| Oct-13-16 | Initiated | CL King | Buy | 
| May-06-15 | Reiterated | Jefferies | Buy | 
| Dec-18-09 | Initiated | Maxim Group | Buy | 
| Nov-06-09 | Initiated | Jefferies & Co | Buy | 
| Jul-17-09 | Initiated | Soleil | Buy | 
| Sep-26-07 | Initiated | Banc of America Sec | Buy | 
| Feb-23-07 | Downgrade | Robert W. Baird | Outperform → Neutral | 
                    View All
                    
                  
                Bio Rad Laboratories Inc Stock (BIO) Latest News
Using R and stats models for Bio Rad Laboratories Inc. forecastingWeekly Investment Recap & Step-by-Step Swing Trade Plans - newser.com
Is Bio Rad Laboratories Inc. forming a bottoming baseJuly 2025 Market Mood & AI Forecasted Stock Moves - newser.com
What macro factors could drive Bio Rad Laboratories Inc. Class stock higherJuly 2025 Snapshot & Target Return Focused Picks - newser.com
What to expect from Bio Rad Laboratories Inc. in the next 30 daysJuly 2025 Catalysts & Reliable Price Action Trade Plans - newser.com
Assetmark Inc. Buys 12,023 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
HbA1c Testing Market Research Report 2025-2033, Profiles of - GlobeNewswire
HbA1c Testing Market Research Report 2025-2033, Profiles of Key PlayersDanaher, F. Hoffmann-La Roche, Siemens, Abbott, Bio-Rad Laboratories, ARKRAY, Trinity Biotech, EKF Diagnostics - Yahoo Finance
How Bio Rad Laboratories Inc. (BUW) stock stacks up against competitorsPortfolio Value Report & Free Safe Entry Trade Signal Reports - newser.com
Will Bio Rad Laboratories Inc. Class B stock deliver stable dividends2025 Price Action Summary & Step-by-Step Swing Trade Plans - newser.com
Why Bio Rad Laboratories Inc. (BUW) stock is upgraded to buyTake Profit & Weekly High Return Forecasts - newser.com
Is Bio Rad Laboratories Inc. meeting your algorithmic filter criteria2025 Retail Activity & Accurate Buy Signal Notifications - newser.com
What valuation ratios show for Bio Rad Laboratories Inc. Class stockMarket Growth Report & Stepwise Trade Signal Implementation - newser.com
How Bio Rad Laboratories Inc. Class B stock responds to bond marketSwing Trade & Free Reliable Trade Execution Plans - newser.com
Understanding Bio Rad Laboratories Inc.’s price movementQuarterly Earnings Summary & Entry Point Confirmation Alerts - newser.com
What market sentiment indicators show for Bio Rad Laboratories Inc. (BUWA) stock2025 Breakouts & Breakdowns & Fast Gain Swing Trade Alerts - newser.com
Is Bio Rad Laboratories Inc. stock poised for growthPortfolio Performance Summary & Short-Term High Return Ideas - newser.com
Is Bio-Rad’s Earnings Miss and Biodesix Partnership Redefining the Investment Outlook for BIO? - Yahoo Finance
Bio Rad Laboratories Inc. stock trend forecast2025 Year in Review & Smart Allocation Stock Reports - newser.com
Will Bio Rad Laboratories Inc. outperform the marketMarket Trend Report & Growth Focused Entry Reports - newser.com
Assessing Bio-Rad Laboratories’s Valuation After Posting a Sharp Quarterly Net Loss Despite Stable Sales - Sahm
Is Bio-Rad (BIO) Sending a New Signal With Expanded Buybacks and Diagnostic Partnerships? - simplywall.st
How Bio Rad Laboratories Inc. (BUW) stock reacts to weak economyPortfolio Profit Report & Reliable Price Breakout Alerts - newser.com
How to build a dashboard for Bio Rad Laboratories Inc. stockDay Trade & Weekly Top Stock Performers List - newser.com
Will Bio Rad Laboratories Inc. stock recover after recent dropPortfolio Profit Report & Real-Time Buy Zone Alerts - newser.com
Will Bio Rad Laboratories Inc. Class stock sustain bullish trend into 2025Gap Up & Entry Point Strategy Guides - newser.com
Will Bio Rad Laboratories Inc. (BUW) stock beat Nasdaq index returns2025 Technical Overview & Real-Time Buy Signal Alerts - newser.com
GAM Holding AG Acquires New Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
What technical charts say about Bio Rad Laboratories Inc. stockEarnings Overview Report & Safe Entry Point Identification - newser.com
Wall Street Zen Upgrades Bio-Rad Laboratories (NYSE:BIO) to Buy - MarketBeat
Is Bio Rad Laboratories Inc. stock a bargain at current levelsJuly 2025 Technicals & AI Powered Buy/Sell Recommendations - newser.com
Will Bio Rad Laboratories Inc. Class stock outperform value peersWeekly Investment Report & Weekly Watchlist of Top Performers - newser.com
Bio-Rad Laboratories (NYSE:BIO.B) Share Price Crosses Above 50-Day Moving AverageTime to Sell? - MarketBeat
Bio-Rad Laboratories, Inc. $BIO Stock Holdings Increased by State of New Jersey Common Pension Fund D - MarketBeat
Can Bio Rad Laboratories Inc. stock sustain revenue growth2025 Price Momentum & Weekly High Return Stock Forecasts - newser.com
What recovery options are there for Bio Rad Laboratories Inc.July 2025 Weekly Recap & Safe Swing Trade Setups - newser.com
Bio-Rad Laboratories (NYSE:BIO.B) Sees Large Volume IncreaseWhat's Next? - MarketBeat
Bio-Rad Laboratories (NYSE:BIO) Given New $375.00 Price Target at Citigroup - MarketBeat
Weiss Ratings Upgrades Bio-Rad Laboratories (NYSE:BIO) to Hold (C-) - MarketBeat
Wells Fargo & Company Raises Bio-Rad Laboratories (NYSE:BIO) Price Target to $340.00 - MarketBeat
Future Scope of Laboratory Reagent Market Set to Witness - openPR.com
Bio-Rad sales up 0.5% to USD 653M in Q3 2025 - Medical Buyer
Bio Rad Laboratories Inc Stock (BIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
        Open in Yahoo
        |
        Open in Google
            |
            Open in Finviz
        |
        Open in MarketWatch
            |
            Open in EDGAR    
        |
        Open in Reuters
    
    
                Cap:
                 
                  | 
                Volume (24h):